Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-08-23 Sale |
2023-08-25 4:07 pm |
JOHNSON & JOHNSON | JNJ | Hait William See Remarks |
696 | $0 | $0 | 87,051 (Direct) |
View |
| 2023-08-23 Sale |
2023-08-25 4:07 pm |
JOHNSON & JOHNSON | JNJ | McEvoy Ashley EVP, WW Chair, MedTech |
2,787 | $0 | $0 | 55,144 (Indirect Direct) |
View |
| 2023-08-23 Sale |
2023-08-25 4:07 pm |
JOHNSON & JOHNSON | JNJ | Fasolo Peter Exec VP, Chief HR Officer |
232 | $0 | $0 | 102,464 (Direct) |
View |
| 2023-08-23 Sale |
2023-08-25 4:07 pm |
JOHNSON & JOHNSON | JNJ | Duato Joaquin CEO and Chairman of the Board |
11,035 | $0 | $0 | 306,217 (Indirect Direct) |
View |
| 2023-08-23 Sale |
2023-08-25 4:07 pm |
JOHNSON & JOHNSON | JNJ | Wolk Joseph J Exec VP, CFO |
67 | $0 | $0 | 52,293 (Indirect Direct) |
View |
| 2023-07-25 Sale |
2023-07-27 5:52 pm |
JOHNSON & JOHNSON | JNJ | Fasolo Peter Exec VP, Chief HR Officer |
20,000 | $170.32 | $3,406,498 | 102,696 (Direct) |
View |
| 2023-07-26 Sale |
2023-07-27 5:52 pm |
JOHNSON & JOHNSON | JNJ | Hait William See Remarks |
14,698 | $172 | $2,528,056 | 87,747 (Direct) |
View |
| 2023-06-12 Sale |
2023-06-14 4:19 pm |
JOHNSON & JOHNSON | JNJ | Wengel Kathryn E EVP, Chief TO and Risk Officer |
12,465 | $160 | $1,994,400 | 66,274 (Indirect Direct) |
View |
| 2023-03-06 Sale |
2023-03-08 4:16 pm |
JOHNSON & JOHNSON | JNJ | Swanson James D. See Remarks |
1,062 | $154.66 | $164,199 | 9,215 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-12-05 Option Award |
2023-12-07 5:17 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | HEWSON MARILLYN A Director |
228 | $159.01 | 8,490 (Direct) |
View |
Ownership |
2023-11-02 4:36 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | Schmid Timothy EVP, WW Chair, MedTech |
0 | $0 | 137,389 (Direct) |
View |
| 2023-09-07 Option Award |
2023-09-11 4:36 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | HEWSON MARILLYN A Director |
229 | $158.63 | 8,201 (Direct) |
View |
| 2023-08-23 Other |
2023-08-25 4:53 pm |
N/A N/A |
Kenvue Inc. | KVUE | JOHNSON & JOHNSON 10% Owner |
1,533,830,450 | $0 | 1,716,160,000 (Direct) |
View |
| 2023-07-26 Exercise |
2023-07-27 5:52 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | Hait William See Remarks |
14,698 | $90.44 | 87,747 (Direct) |
View |
| 2023-07-26 Exercise |
2023-07-27 5:52 pm |
2017-02-11 2024-02-09 |
JOHNSON & JOHNSON | JNJ | Hait William See Remarks |
14,698 | $0 | 87,747 (Direct) |
View |
| 2023-06-06 Option Award |
2023-06-08 4:10 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | HEWSON MARILLYN A Director |
230 | $157.52 | 7,913 (Direct) |
View |
| 2023-05-24 Gift |
2023-05-25 4:52 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | Wolk Joseph J Exec VP, CFO |
55 | $0 | 52,345 (Direct) |
View |
Ownership(A) |
2023-05-10 4:18 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | Johnson Paula A Director |
0 | $0 | 102 (Indirect) |
View |
Ownership |
2023-05-03 4:16 pm |
N/A N/A |
Kenvue Inc. | KVUE | JOHNSON & JOHNSON 10% Owner |
0 | $0 | 1,716,160,000 (Direct) |
View |
| 2023-05-01 Option Award |
2023-05-02 5:21 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | REED JOHN C EVP, Pharmaceuticals R&D |
75,765 | $0 | 75,765 (Direct) |
View |
| 2023-04-27 Option Award |
2023-05-02 5:21 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | West Nadja Director |
1,194 | $0 | 3,599 (Direct) |
View |
| 2023-04-27 Option Award |
2023-05-02 5:21 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | WEINBERGER MARK A Director |
1,194 | $0 | 7,516 (Direct) |
View |
| 2023-04-27 Option Award |
2023-05-02 5:21 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | MULCAHY ANNE M Director |
1,194 | $0 | 19,494 (Direct) |
View |
| 2023-04-27 Option Award |
2023-05-02 5:21 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | Johnson Paula A Director |
1,430 | $0 | 1,430 (Direct) |
View |
| 2023-04-27 Option Award |
2023-05-02 5:21 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | HEWSON MARILLYN A Director |
1,194 | $0 | 7,625 (Direct) |
View |
| 2023-04-27 Option Award |
2023-05-02 5:21 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | McClellan Mark B. Director |
1,194 | $0 | 15,997 (Direct) |
View |
| 2023-04-27 Option Award |
2023-05-02 5:21 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | Joly Hubert Director |
1,194 | $0 | 4,929 (Direct) |
View |
| 2023-04-27 Option Award |
2023-05-02 5:21 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | Doudna Jennifer A Director |
1,194 | $0 | 6,499 (Direct) |
View |
| 2023-04-27 Option Award |
2023-05-02 5:21 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | Beckerle Mary C Director |
1,194 | $0 | 11,897 (Direct) |
View |
| 2023-04-27 Option Award |
2023-05-02 5:20 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | DAVIS D SCOTT Director |
1,194 | $0 | 13,799 (Direct) |
View |
| 2023-04-27 Option Award |
2023-05-02 5:20 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | Adamczyk Darius Director |
1,194 | $0 | 2,259 (Direct) |
View |
Ownership |
2023-04-13 5:10 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | REED JOHN C EVP, Pharmaceuticals R&D |
0 | $0 | 306 (Direct) |
View |
| 2023-03-07 Option Award |
2023-03-09 5:41 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | Washington A. Eugene Director |
201 | $155.16 | 28,569 (Direct) |
View |
| 2023-03-07 Option Award |
2023-03-09 5:41 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | HEWSON MARILLYN A Director |
234 | $155.16 | 6,431 (Direct) |
View |
Ownership |
2023-02-22 12:59 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | Johnson Paula A Director |
0 | $0 | 100 (Direct) |
View |
| 2023-02-13 Option Award |
2023-02-15 7:25 pm |
N/A 2033-02-13 |
JOHNSON & JOHNSON | JNJ | Wolk Joseph J Exec VP, CFO |
114,365 | $0 | 146,057 (Direct) |
View |
| 2023-02-13 Tax Withholding |
2023-02-15 7:25 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | Wolk Joseph J Exec VP, CFO |
8,578 | $162.01 | 146,057 (Direct) |
View |
| 2023-02-13 Option Award |
2023-02-15 7:25 pm |
N/A 2033-02-13 |
JOHNSON & JOHNSON | JNJ | Wengel Kathryn E EVP, Chief TO and Risk Officer |
45,109 | $0 | 113,004 (Direct) |
View |
| 2023-02-13 Tax Withholding |
2023-02-15 7:25 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | Wengel Kathryn E EVP, Chief TO and Risk Officer |
4,891 | $162.01 | 113,004 (Direct) |
View |
| 2023-02-13 Option Award |
2023-02-15 7:25 pm |
N/A 2033-02-13 |
JOHNSON & JOHNSON | JNJ | Taubert Jennifer L EVP, WW Chair, Pharmaceuticals |
89,962 | $0 | 208,130 (Direct) |
View |
| 2023-02-13 Tax Withholding |
2023-02-15 7:25 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | Taubert Jennifer L EVP, WW Chair, Pharmaceuticals |
10,569 | $162.01 | 208,130 (Direct) |
View |
| 2023-02-13 Option Award |
2023-02-15 7:25 pm |
N/A 2033-02-13 |
JOHNSON & JOHNSON | JNJ | Swanson James D. See Remarks |
26,760 | $0 | 33,809 (Direct) |
View |
| 2023-02-13 Tax Withholding |
2023-02-15 7:25 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | Swanson James D. See Remarks |
918 | $162.01 | 33,809 (Direct) |
View |
| 2023-02-13 Option Award |
2023-02-15 7:25 pm |
N/A 2033-02-13 |
JOHNSON & JOHNSON | JNJ | Mongon Thibaut Exec VP, WW Chair, Cons Health |
73,682 | $0 | 125,887 (Direct) |
View |
| 2023-02-13 Tax Withholding |
2023-02-15 7:25 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | Mongon Thibaut Exec VP, WW Chair, Cons Health |
6,430 | $162.01 | 125,887 (Direct) |
View |
| 2023-02-13 Option Award |
2023-02-15 7:24 pm |
N/A 2033-02-13 |
JOHNSON & JOHNSON | JNJ | McEvoy Ashley EVP, WW Chair, MedTech |
82,993 | $0 | 122,847 (Direct) |
View |
| 2023-02-13 Tax Withholding |
2023-02-15 7:24 pm |
N/A N/A |
JOHNSON & JOHNSON | JNJ | McEvoy Ashley EVP, WW Chair, MedTech |
7,158 | $162.01 | 122,847 (Direct) |
View |